Coffee is a rich source of bioactive compounds that have potential anticarcinogenic effects. However, it remains unclear whether coffee drinking is associated with colorectal cancer. Also, despite different etiological factors involved in gut physiology, few studies have investigated this association by anatomical site of the lesion. To address these issues, this study examined the association between coffee drinking and colorectal cancer in a pooled analysis from 8 cohort studies conducted in Japan. Among 320,322 participants followed up for 4,503,274 person-years, 6,711 incident colorectal cancer cases were identified. Study-specific hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models and then pooled using the random effects model. Coffee drinking was not materially associated with colorectal cancer risk in men or women (pooled HR 0.92, 95% CI 0.82-1.03 in men and pooled HR 0.90, 95% CI 0.76-1.07 in women). Analysis by subsite showed a lower risk of colon cancer among female drinkers of 3 cups coffee/day (pooled HR 0.80, 95% CI 0.64-0.99). There was no such association in men. Coffee drinking was not associated with risk of rectal cancer in men or women. Results were virtually the same among never smokers except for an increased risk of rectal cancer associated with frequent coffee consumption. Coffee drinking may be associated with lower risk of colon cancer in Japanese women.
While coffee consumption has been consistently, inversely associated with risk of cancer of the liver 10 and uterus, 11 the association with colorectal cancer remains unclear. So far, three meta-analyses [12] [13] [14] of cohort studies reported no significant association between coffee consumption and colorectal cancer, although another meta-analysis 15 reported a significant inverse association. Such inconsistency may partly be ascribed to heterogeneous association dependent on study population and colorectal subsite. In fact, some studies showed a significant protective association in Asian women but not in Asian men 12 and a risk reduction in the proximal colon but not in the distal colon or rectum. 16 Given close correlation between coffee drinking and smoking 16, 17 ; however, concerns have been raised about potential bias due to residual confounding by smoking (a known risk factor for colorectal cancer 18 ). An analysis of lifetime nonsmokers may show clearer evidence of an association between coffee drinking and colorectal cancer.
Coffee drinking is increasingly popular in Japan (mean consumption among adults, 11 cups/week) 19 ; thus, it would be of great interest to know whether coffee consumption is associated with risk of colorectal cancer in this population. In our previous meta-analysis using published data from Japanese cohorts, we found no measurable association, 20 a finding consistent with previous meta-analyses. [12] [13] [14] Meta-analysis using existing data, however, may not be sensitive enough to detect an association, if any, due to the difference among studies in exposure definition and factors adjusted for in analysis. Here, we conducted a pooled analysis among 320,322 participants of 8 major cohort studies in Japan of the association between coffee drinking and cancer of the colorectum and its subsites, using the same exposure categories and adjusting for similar covariates across studies.
Materials and Methods

Study populations
The Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan has been conducting pooled analyses using original data from major cohort studies to examine associations between lifestyle and major forms of cancers in Japanese since 2006. To maintain high quality and comparability of data, the following inclusion criteria were defined a priori for the present analysis: population-based cohort studies were conducted in Japan, the studies were initiated between the mid-1980s and mid-1990s, the studies included >30,000 participants, the studies obtained dietary information including coffee drinking in a baseline survey with a validated questionnaire, the studies collected incidence data for colorectal cancer during a follow-up period. We identified eight studies that met these criteria: (1) the Japan Public Health Center-based Prospective Study-I (JPHC-I) 21 ; (2) 25 ; (7) the Three Prefecture Study-Aichi portion (3-pref AICHI) 25 ; (8) the Three Prefecture StudyOsaka portion (3-pref OSAKA). 25 We excluded data for participants with missing information in sex, age, area (only for JPHC and JACC study) or coffee drinking and with a history of cancer at baseline. Each study was approved by the relevant institutional ethical review boards. The MIYAGI, JPHC, and JACC have already reported results on the associations between coffee drinking and colorectal cancer risk. [26] [27] [28] For the present analysis, we reanalyzed the updated dataset for MIYAGI, JPHC, and JACC studies. Selected characteristics of these cohort studies are shown in Table 1 . . 29 Cases were coded according to the International Classification of Diseases for Oncology, Third Edition (ICD-O-3). 30 The study outcome was defined as incident colorectal cancer (ICD-O-3, codes C18.0-18.9, C19 and C20), colon cancer (ICD-O-3, codes C18.0-18.9), rectal cancer (ICD-O-3, codes C19.9 and C20.9), proximal colon cancer (ICD-O-3, codes C18.0-18.5), and distal colon cancer (ICD-O-3, codes C18.6-18.7) diagnosed during the respective follow-up periods of each study.
Assessment of coffee drinking
Coffee drinking was assessed by self-administered questionnaires at baseline. Although the style of the questions differed by study, each study obtained information in terms of frequency and amount of coffee drinking. Drinking was divided What's new? Drinking coffee may protect Japanese women from colon cancer, according to new analysis. These authors conducted a pooled analysis of 320,322 participants from 8 cohort studies out of Japan to investigate the effect of coffee drinking on risk of colorectal cancer. They found no protective or harmful effect on colorectal cancers in men or women. However, when they stratified the data by cancer site, they found a lower risk of colon cancer among women who said they drank 3 or more cups of coffee per day. into categories using identical cut points across studies: <1 cup/day (reference), 1-2 cups/day, and 3 cups/day. In most of the collaborating cohorts, coffee consumption was asked with response options including those for higher consumption category (i.e., 5 cups/day). We combined, however, categories above 3 cups/day as the highest group for analysis because <3% participants of the JACC cohort, where coffee consumption was measured in a continuous scale, drunk coffee 4 cups/day at the time of the baseline survey. Correlation coefficients between coffee drinking assessed by the questionnaire and the dietary record were 0.42 in men and 0.38 in women for JPHC, 31 0.81 for JACC, 28 and 0.70 for the Miyagi study. 26 The OHSAKI, 3-pref MIYAGI, 3-pref AICHI, and 3-pref OSAKA studies-for which information on validation of coffee drinking was not available-utilized the same questions on coffee drinking as the Miyagi cohort study.
Statistical analysis
Person-years of follow-up were calculated from the date of baseline survey in each study until the date of colorectal cancer diagnosis, migration from the study area, death or the end of follow up, whichever came first. In each individual study, Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of cancer of the colorectum or its subsites. The HRs were computed for the second through the highest categories versus the lowest category of coffee consumption. All studies estimated two types of HRs: age-(continuous) and areaadjusted (within each study for JPHC-I, JPHC-II, and JACC) HR and multivariate-adjusted HR. The multivariate-adjusted model included, in addition to age and area adjustments, history of diabetes (yes or no), body mass index (weight (kg)/ height (m) 2 ; 14 to <18.5, 18.5 to <22, 22 to <25, 25 to <30, or 30 to <40), smoking status (for men: never smoker, past smoker, current smoker of 1-19 cigarettes/day, or current smoker of 20 cigarettes/day; for women: never smoker, past smoker, or current smoker), alcohol drinking (for men: never/former drinker, occasional drinker of <once/week, or current drinker of <23, 23 to <46, 46 to <69, 69 to <92, or 92 ethanol g/day; for women: never/former drinker, occasional drinker of <once/week, or current drinker of <23, or 23 ethanol g/day), nonoccupational physical activity (JPHC I and JPHC II: almost never, 1-3 days/month, or 1 day/ week; JACC, MIYAGI, and OHSAKI: almost never or 1 hr/ week), log-transformed energy intake (continuous), energyadjusted dietary intake of red meat intake containing beef, pork, and liver (quartiles), processed meat (quartiles), calcium (quartiles), and fiber (quartiles). The 3-pref MIYAGI, 3-pref AICHI, and 3-pref OSAKA studies, for which information on red meat, calcium, and fiber intake was not available, adjusted for all types of meat intake including processed meat (2 days/week, 3-4 days/week, or almost every day); milk (2 days/week, 3-4 days/week, or almost every day); green and yellow-colored vegetable intake (2 days/week, 3-4 days/week, or almost every day) as substitutes. Additionally, energy intake data were not available in the 3-pref MIYAGI, 3-pref AICHI, and 3-pref OSAKA studies. An indicator term for missing data was created for each covariate. We performed sensitivity analysis by excluding cases diagnosed within 3 years of baseline. We repeated analyses in never smokers only. The trend association was assessed by calculating the regression coefficient and its standard error of linear trend in each model, with ordinal numbers 0-2 assigned to the three categories of coffee drinking. All the analyses were done using SAS (Version 9.3; SAS Institute, Inc., Cary, NC) or Stata (Version 13; Stata Corporation, College Station, TC) statistical software.
Resultant HRs from all of the eight cohorts for each category were combined using a random effects model. 32 A study that had no cases for a category was not included in the pooled estimate for that category. The trend association was assessed by combining the regression coefficients and standard errors of linear trend across the participating cohorts by a random-effects model. The extent of heterogeneity for each category was indicated by Cochran's Q-statistic, 32 which was considered statistically significant when the p values was <0.10. The I 2 -statistic was also reported to describe the percentage of total variation in the study-specific HRs which was due to heterogeneity. The differences in association between groups (men versus women, colon versus rectum, and proximal colon versus distal colon) were assessed using meta-regression analysis. We used the "metan" command in Stata for meta-analysis.
Results
The present pooled analysis included 8 large-scale population-based prospective cohort studies comprising 320,322 participants (149,934 men and 170,388 women) and 6711 colorectal cancer cases (4022 for men and 2689 for women) during 4,503,274 person-years of follow-up (Table 1) . About 45% of men and 40% of women consumed 1 cup of coffee per day.
Overall, we found no statistically significant associations between coffee drinking and colorectal cancer in multivariateadjusted models in men (Table 2 ). In site-specific analyses, men consuming 3 cups/day of coffee showed a significant decrease in the risk of colon cancer compared with men consuming <1 cup/day of coffee (HR 0.86, 95% CI 0.76-0.99) in the age-and area-adjusted model (p-trend 5 0.04). This association was, however, attenuated after adjustment for other potential confounders (HR 0.91, 95% CI 0.79-1.04). Coffee drinking was not associated with risk of rectal cancer in men. The test for heterogeneity across studies was not statistically significant for any site. There was no significant difference in association between colon and rectum in men (p 5 0.25) (Supporting Information, Table 1 ). No significant association was observed for any subsite of the colon: multivariate-adjusted HR (95% CI) comparing 3 cups/day of coffee versus <1 cup/day of coffee was 1.04 (0.84-1.29) for the proximal colon and 0.87 (0.71-1.06) for the distal colon ( Table 2) . The difference in association between proximal colon and distal colon was not significant in men (p 5 0.23) (Supporting Information, Table 1 ).
Similarly, there was no association between coffee drinking and colorectal cancer in women (Table 3) . With regard to colon cancer, however, a significant inverse association with coffee drinking was observed: the multivariate-adjusted HR for 3 cups/day versus <1 cup/day of coffee was 0.80 (95% Cl 0.64-0.99). The association seems slightly stronger for the proximal colon than for distal colon (HR for proximal colon 0.78, 95% CI 0.57-1.06 versus HR for distal colon 0.90, 95% CI 0.64-1.26), but the difference by subsite of the colon was not statistically significant (p 5 0.55) (Supporting Information, Table 1 ). Coffee drinking was not 1 Adjusted for age (continuous), area, history of diabetes (yes or no), body mass index (BMI: kg/m 2 ); 14 to <18.5, 18.5 to <22, 22 to <25, 25 to <30, or 30 to <40, smoking status (never smoker, past smoker, current smoker of 1-19 cigarettes/day, or current smoker of 20 cigarettes/day), alcoholic drinking (never/former drinker, occasional drinker of less than once a week, or current drinker of <23, 23 to <46, 46 to <69, 69 to <92, or 92 ethanol g/day), nonoccupational physical activity (JPHC I and JPHC II: almost never, 1-3 days/month, or 1 day/week; JACC, MIYAGI, and OHSAKI: almost never or 1 hr/week), log-transformed energy intake (continuous), energy-adjusted dietary intake of red meat intake containing beef, pork, and liver (quartiles), processed meat (quartiles), calcium (quartiles), and fiber (quartiles). The 3-pref MIYAGI, 3-pref AICHI, and 3-pref OSAKA studies, for which information on red meat, calcium, and fiber intake was not available, adjusted for all type of meat intake including processed meat (2 days/week, 3-4 days/week, or almost every day), milk (2 days/week, 3-4 days/week, or almost every day), and green and yellow-colored vegetable intake (2 days/week, 3-4 days/week, or almost every day) as substitutes. 2 For the highest category.
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associated with risk of rectal cancer, although a significantly increased risk of rectal cancer was observed after excluding cases diagnosed within 3 years of the baseline (HR1.36, 95% Cl 1.02-1.83; p trend 5 0.07). There was a significant difference in association between colon and rectum in women (p 5 0.03) (Supporting Information, Table 1 ). The test for heterogeneity across studies was not statistically significant for any site.
There was no significant sex difference in association for total and any given subsite of the colorectum (the p values for colorectum, colon, rectum, proximal colon, and distal colon were 0.44, 0.32, 0.44, 0.44, and 0.44, respectively) (Supporting Information, Table 2 ).
Results of analyses among never smokers were virtually the same for cancer of the colorectum or colon (Table 4) . Risk of colon cancer associated with the highest consumption 1 Adjusted for age (continuous), area, history of diabetes (yes or no), body mass index (BMI: kg/m2); 14 to <18.5, 18.5 to <22, 22 to <25, 25 to <30, or 30 to <40, smoking status (never smoker, past smoker, or current smoker), alcoholic drinking (never/former drinker, occasional drinker of less than once a week, or current drinker of <23 or 23 ethanol g/day), non-occupational physical activity (JPHC I and JPHC II: almost never, 1-3 days/month, or 1 day/week; JACC, MIYAGI, and OHSAKI: almost never or 1 hr/week), log-transformed energy intake (continuous), energy-adjusted dietary intake of red meat intake containing beef, pork, and liver (quartiles), processed meat (quartiles), calcium (quartiles), and fiber (quartiles). The 3-pref MIYAGI, 3-pref AICHI, and 3-pref OSAKA studies, for which information on red meat, calcium, and fiber intake was not available, adjusted for all type of meat intake including processed meat (2 days/week, 3-4 days/week, or almost every day), milk (2 days/week, 3-4 days/week, or almost every day), and green and yellow-colored vegetable intake (2 days/week, 3-4 days/week, or almost every day) as substitutes. 2 For the highest category. 
Discussion
In this pooled analysis involving 320,322 participants and 6711 incident colorectal cancers from 8 population-based cohort studies in Japan, we found no clear association between coffee drinking and colorectal cancer for men or women. In site-specific analyses, coffee drinking was significantly and inversely associated with colon cancer but not for rectal cancer in women, whereas it was neither associated with colon nor rectal cancer in men.
The null findings of coffee drinking with total colorectal cancer is consistent with three systematic review and metaanalyses of worldwide studies 12, 13, 15 and with pooled analysis of prospective cohort studies in North America and Europe. 33 The present findings are also consistent with our previous meta-analysis of Japanese cohort studies, 20 where no association was found between coffee consumption and colorectal cancer. In a large US cohort study, 16 which had higher numbers of incident colorectal cancers (n 5 6946) than the above pooled study or other meta-analyses, coffee drinking was significantly inversely associated with risk of colorectal cancer. The authors of the US cohort study ascribed their findings to the use of a standard questionnaire in a single defined population and a comparatively higher number of incident cases. In this study, incident colorectal cancer was also considerable (n 5 6711), and coffee consumption was categorized uniformly (although questions and response options differed slightly across studies). Nevertheless, we found no association between coffee drinking and colorectal cancer. This inconsistency may be partly attributed to the difference of coffee consumption between the study populations. The US cohort study 16 detected a reduction in risk only for those who drank 4-5 cups/day and 6 cups/day but not for those who drank 3 cups/day, as compared to non-coffee-drinkers. Interestingly, a meta-analysis of prospective cohort studies showed that coffee drinking was not associated with colorectal cancer risk in an analysis comparing the high versus low consumption (HR 0.98), whereas coffee drinking was significantly inversely associated with risk of colorectal cancer in a doseresponse analysis comparing those consuming 6 cups/day with nondaily drinkers (HR 0.93, 0.90, and 0.87 for 6 cups/ day, 7 cups/day and 8 cups/day, respectively), 34 suggesting a threshold for whatever anticarcinogenic effect there may be for coffee drinking.
In site-specific analysis, we found a significant 20% reduced risk of colon cancer in women who drank 3 cups/ day of coffee compared to those who drank <1 cup/day. The present findings are consistent with a previous meta-analysis of cohort studies, 12 where a 39% lower risk of colon cancer was observed in the highest category of coffee consumption compared to the lowest category in Asian women. Within the colon, we observed a slightly stronger association in the proximal colon than in the distal colon, although the difference was not statistically significant. More clear differential association was recently reported in a case-control study among Japanese 35 ; women who drank 3 cups/day of coffee had a decreased risk for proximal colon cancer but not for distal colon cancer. Further studies are required to confirm or refute whether the association differ by anatomical site of the colon.
There was no association between coffee drinking and rectal cancer in women and men in total. Among never smokers, however, an increased risk was observed in both women and men. Meta-analyses of prospective cohort studies worldwide 12, 13, 34 and in Japan 20 did not detect any increase in the risk of rectal cancer associated with coffee drinking. The observed association with rectal cancer in the present subgroup analyses should be interpreted with caution due to the small number of cases comprising the subgroup.
Coffee drinking has been hypothesized to decrease the risk of colon cancer through several mechanisms. Coffee consumption may reduce the synthesis and secretion of bile acids, 36 which is a potential promoter of colon carcinogenesis. 37 Coffee consumption may also increase colonic motility, 38 which can then decrease the exposure of epithelial cells to potential carcinogens in the colon. 39 In addition, coffee contains several phytochemicals that can exhibit anticarcinogenic properties. 40, 41 Bioactive compounds in coffee including diterpenes cafestol and kahweal can induce phase I and II enzyme activities. 42, 43 Polyphenols, such as flavonoids and chlorogenic acid, have antioxidant properties 44 and can decrease insulin resistance. 45 Furthermore, several micronutrients in coffee-including magnesium, potassium, niacin, and vitamin E-may also contribute to decrease the risk of colon cancer. 39, 46 This study has several strengths. First, we conducted a meta-analysis of data of major cohort studies in Japan using a validated dietary questionnaire and used identical categories for coffee consumption across our incorporated studies. Second, each study controlled for a common set of variables that are known or suggested to be associated with colorectal cancer. Third, with a large number of participants and incident cases of colorectal cancer, we were able to examine the effect of coffee with reasonable statistical power.
Our study also has some limitations. First, we used only baseline information on coffee consumption and did not consider lifetime consumption or changes of consumption during follow-up. Second, although each study adjusted for important factors associated with colorectal cancer, we cannot exclude the possibility of residual confounding. Third, each study estimated coffee consumption using data on drinking frequency, potentially causing a misclassification of coffee consumption. We assumed, however, that the size of
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Kashino et al. , non-occupational physical activity (JPHC I and JPHC II: almost never, 1-3 days/month or 1 day/week; JACC, MIYAGI, and OHSAKI: almost never or 1 hr/week), log-transformed energy intake (continuous), energy-adjusted dietary intake of red meat intake containing beef, pork, and liver (quartiles), processed meat (quartiles), calcium (quartiles), and fiber (quartiles). The 3-pref MIYAGI, 3-pref AICHI, and 3-pref OSAKA studies, for which information on red meat, calcium and fiber intake was not available, adjusted for all type of meat intake including processed meat (2 days/week, 3-4 days/week, or almost every day), milk (2 days/week, 3-4 days/week, or almost every day), and green and yellow-colored vegetable intake (2 days/week, 3-4 days/week, or almost every day) as substitutes. 2 For the highest category.
the standard cup did not largely differ among the studies included here. Fourth, we have no data on the types of coffee consumed (caffeinated or decaffeinated coffee), or roasting and brewing methods, which likely affect the concentration of different compounds in coffee.
In conclusion, this pooled analysis of data from large prospective studies in Japan with considerable number of subjects and incident colorectal cancer cases found no association between coffee drinking and colorectal cancer in men or women. In site-specific analysis, coffee drinking was significantly and inversely associated with colon cancer in women. Further investigation is required to elucidate the mechanisms underlying the differential association by colorectal subsite. Taichi 
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